Cargando…

Improving access to medicines via the Health Impact Fund in India: a stakeholder analysis

Background: In India, 50–65% of the population face difficulties in accessing medicines. The Health Impact Fund (HIF) is a novel proposal whereby pharmaceutical companies would be paid based on the measured global health impact of their drugs. We conducted a key stakeholder analysis to explore acces...

Descripción completa

Detalles Bibliográficos
Autores principales:	McMullan, Patrick, Ajay, Vamadevan S., Srinivas, Ravi, Bhalla, Sandeep, Prabhakaran, Dorairaj, Banerjee, Amitava
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844053/ https://www.ncbi.nlm.nih.gov/pubmed/29495950 http://dx.doi.org/10.1080/16549716.2018.1434935

Ejemplares similares

Drugs for cardiovascular disease in India: perspectives of pharmaceutical executives and government officials on access and development-a qualitative analysis
por: Newman, Charles, et al.
Publicado: (2016)

Coronary heart disease in Indians: Implications of the INTERHEART study
por: Ajay, Vamadevan S., et al.
Publicado: (2010)

"Heart Failure: Meeting the Challenges of Surveillance and Knowledge Translation in Resource-poor Settings"
por: Safraj, Shahulhameed, et al.
Publicado: (2013)

India and the United Kingdom—What big data health research can do for a country
por: Bandopadhyay, Souvik, et al.
Publicado: (2018)

Development of a Smartphone‐Enabled Hypertension and Diabetes Mellitus Management Package to Facilitate Evidence‐Based Care Delivery in Primary Healthcare Facilities in India: The mPower Heart Project
por: Ajay, Vamadevan S., et al.
Publicado: (2016)

m-Power Heart Project - a nurse care coordinator led, mHealth enabled intervention to improve the management of hypertension in India: study protocol for a cluster randomized trial
por: Srinivasapura Venkateshmurthy, Nikhil, et al.
Publicado: (2018)

Association between socioeconomic position and cardiovascular disease risk factors in rural north India: The Solan Surveillance Study
por: Agarwal, Anubha, et al.
Publicado: (2019)

Stakeholders’ perceptions regarding a salt reduction strategy for India: Findings from qualitative research
por: Gupta, Priti, et al.
Publicado: (2018)

Adherence to diabetes care processes at general practices in the National Capital Region-Delhi, India
por: Shivashankar, Roopa, et al.
Publicado: (2016)

Cardiovascular risk prediction in India: Comparison of the original and recalibrated Framingham prognostic models in urban populations.
por: Gupta, Priti, et al.
Publicado: (2019)

A cluster-randomized controlled trial to evaluate the effects of a simplified cardiovascular management program in Tibet, China and Haryana, India: study design and rationale
por: Ajay, Vamadevan S, et al.
Publicado: (2014)

Global Cardiovascular Research Output, Citations, and Collaborations: A Time-Trend, Bibliometric Analysis (1999–2008)
por: Huffman, Mark D., et al.
Publicado: (2013)

Disparities in Cardiovascular Research Output and Citations From 52 African Countries: A Time‐Trend, Bibliometric Analysis (1999–2008)
por: Bloomfield, Gerald S., et al.
Publicado: (2015)

Psychiatrists are stakeholders in improving access to controlled medicines
por: Scholten, Willem
Publicado: (2011)

Cardiovascular disease in India: Lessons learnt & challenges ahead
por: Prabhakaran, Dorairaj, et al.
Publicado: (2010)

Process evaluation protocol for a cluster randomised trial of a complex, nurse-led intervention to improve hypertension management in India
por: Srinivasapura Venkateshmurthy, Nikhil, et al.
Publicado: (2019)

Collaborative Quality Improvement Strategy in Secondary Prevention of Cardiovascular Disease in India: Findings from a Multi-Stakeholder, Qualitative Study using Consolidated Framework for Implementation Research (CFIR)
por: Singh, Kavita, et al.
Publicado: (2022)

Pension fund excellence: creating value for stakeholders
por: Ambachtsheer, Keith P., et al.
Publicado: (1998)

Stakeholder controls and conflicts in research funding and publication
por: Buckley, Ralf C.
Publicado: (2022)

World Hypertension Day: Contemporary issues faced in India
por: Jose, Arun Pulikkottil, et al.
Publicado: (2019)

Premature coronary heart disease risk factors & reducing the CHD burden in India
por: Prabhakaran, Dorairaj, et al.
Publicado: (2011)

Developing cardiovascular disease risk programs in India—Why location and wealth matter
por: Peiris, David, et al.
Publicado: (2018)

The impact of patient-reported outcome data from clinical trials: perspectives from international stakeholders
por: Cruz Rivera, Samantha, et al.
Publicado: (2020)

Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in India
por: Jha, Dilip, et al.
Publicado: (2017)

Establishing research priorities relating to the long-term impact of TIA and minor stroke through stakeholder-centred consensus
por: Turner, Grace M., et al.
Publicado: (2018)

Healthcare providers’ perspective of COVID-19 pandemic on cancer treatment, screening & early detection services in India
por: Kaushik, Aprajita, et al.
Publicado: (2022)

Perspectives of pharmaceutical stakeholders on determinants of medicines accessibility at the primary care level
por: Rizk, Hoda Ibrahim, et al.
Publicado: (2021)

A partnership model for capacity-building of primary care physicians in evidence-based management of diabetic retinopathy in India
por: Bhalla, Sandeep, et al.
Publicado: (2020)

What are the Evidence Based Public Health Interventions for Prevention and Control of NCDs in Relation to India?
por: Singh, Kavita, et al.
Publicado: (2011)

Exploring Barriers to Medication Adherence Using COM-B Model of Behaviour Among Patients with Cardiovascular Diseases in Low- and Middle-Income Countries: A Qualitative Study
por: Mishra, Pallavi, et al.
Publicado: (2021)

Development, improvement and funding of the emergency medicine cases open-access podcast
por: Chartier, Lucas B., et al.
Publicado: (2016)

Healthcare utilisation and expenditure patterns for cardio-metabolic diseases in South Asian cities: the CARRS Study
por: Gupta, Priti, et al.
Publicado: (2020)

Multimorbidity or multiple long-term conditions: need for bridging the evidence & care gaps to address an emerging priority public health issue in India
por: Gupta, Priti, et al.
Publicado: (2022)

The Innovative Medicines Fund: a universal model for faster and fairer access to new promising medicines or a Trojan horse for low-value creep?
por: Angelis, Aris, et al.
Publicado: (2023)

A qualitative analysis of stakeholder experiences with Registered Reports Funding Partnerships
por: Drax, Katie, et al.
Publicado: (2021)

Pre-hospital ECG for acute coronary syndrome in urban India: A cost-effectiveness analysis
por: Schulman-Marcus, Joshua, et al.
Publicado: (2010)

Development of mWellcare: an mHealth intervention for integrated management of hypertension and diabetes in low-resource settings
por: Jindal, Devraj, et al.
Publicado: (2018)

Hemodialysis Access Type and Access Patency Loss: An Observational Cohort Study
por: Roetker, Nicholas S., et al.
Publicado: (2022)

Funding the Way to Open Access
por: Terry, Robert
Publicado: (2005)

Improving care for hypertension and diabetes in india by addition of clinical decision support system and task shifting in the national NCD program: I-TREC model of care
por: Jindal, Devraj, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cfdbniv0e1adohdkq34k3af0lk